Hardin Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
4,632
-289
-6% -$67.4K 0.55% 35
2026
Q1
$1.2M Sell
4,921
-26
-0.5% -$6.06K 0.56% 32
2025
Q4
$1.02M Buy
4,947
+311
+7% +$61.5K 0.48% 37
2025
Q3
$860K Buy
4,636
+13
+0.3% +$2.23K 0.46% 41
2025
Q2
$721K Sell
4,623
-330
-7% -$50.7K 0.42% 43
2025
Q1
$821K Sell
4,953
-69
-1% -$10.8K 0.5% 34
2024
Q4
$726K Sell
5,022
-318
-6% -$49.3K 0.44% 37
2024
Q3
$853K Buy
5,340
+14
+0.3% +$2.23K 0.48% 32
2024
Q2
$778K Buy
+5,326
New +$792K 0.51% 32

Other funds holding JNJ

Hardin Capital Partners's JNJ Position: Q2 2026 in Review

Hardin Capital Partners reduced its Johnson & Johnson (JNJ) stake by 5.9% in Q2 2026, selling an estimated $67.4K and leaving 4,632 shares worth $1.18M. The position accounts for 0.55% of the portfolio, ranked #35.

Hardin Capital Partners first reported a position in JNJ in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.2M in Q1 2026. 2,980 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Hardin Capital Partners held 4,632 shares of Johnson & Johnson worth $1.18M as of Q2 2026.
  • Hardin Capital Partners sold 289 Johnson & Johnson shares in Q2 2026, an estimated $67.4K.
  • Johnson & Johnson made up 0.55% of Hardin Capital Partners's portfolio in Q2 2026, its #35 holding.
  • Hardin Capital Partners first reported a position in Johnson & Johnson in Q2 2024 and has held it in 9 quarters since.
  • Hardin Capital Partners's Johnson & Johnson position peaked at $1.2M in Q1 2026.
  • 2,980 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Hardin Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.